Tantipraphat Lita, Sudhinaraset Narakit, Thongmee Thanunrat, Kanokudom Sitthichai, Nilyanimit Pornjarim, Sudhinaraset Natthinee, Poovorawan Yong
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Am J Trop Med Hyg. 2025 Apr 29;113(1):86-93. doi: 10.4269/ajtmh.24-0857. Print 2025 Jul 2.
Epstein-Barr virus (EBV) infects over 90% of the global population and establishes lifelong persistence. Although early childhood infections are often asymptomatic, EBV infection during adolescence can cause infectious mononucleosis, several malignancies, and posttransplant lymphoproliferative disorders. The timing of EBV infection and seroprevalence varies globally based on geographic and socioeconomic factors; however, comprehensive and updated data for Thailand are limited. This study investigated EBV seroprevalence across age groups in four provinces representing Thailand's regions, comparing findings with previous data and exploring correlations with economic and health care indicators. Serum samples (N = 1,274) were collected between May and August 2024 from participants ages 6 months old to 80 years old in Ayutthaya, Uttaradit, Buri Ram, and Trang provinces. EBV capsid antigen IgG levels were measured using ELISA. Age-specific seroprevalence increased from 35.9% in infants (6 months old to 2 years old) to nearly 100% in adolescents and adults, with varying antibody levels between age groups. Comparisons with historical data illustrated consistent trends of early EBV acquisition in childhood, but the infection increased slightly slower than in the past. Compared with other countries, EBV seroprevalence in Thailand and other developing countries occurred earlier than in developed countries. Linear regression analysis revealed a significant correlation between age at 50% and 75% EBV seropositive and a national economic indicator (gross domestic product per capita). These findings found little changes in EBV epidemiology over time and provided updated information and analysis to support public health strategies.
爱泼斯坦-巴尔病毒(EBV)感染了全球超过90%的人口,并建立终身持续性感染。虽然幼儿期感染通常无症状,但青少年时期的EBV感染可导致传染性单核细胞增多症、多种恶性肿瘤以及移植后淋巴增生性疾病。EBV感染的时间和血清阳性率因地理和社会经济因素在全球范围内有所不同;然而,泰国的全面且最新的数据有限。本研究调查了代表泰国不同地区的四个省份各年龄组的EBV血清阳性率,将结果与先前数据进行比较,并探索与经济和医疗保健指标的相关性。2024年5月至8月期间,从大城府、乌泰他尼府、武里南府和董里府6个月至80岁的参与者中收集了血清样本(N = 1274)。使用酶联免疫吸附测定法测量EBV衣壳抗原IgG水平。年龄特异性血清阳性率从婴儿(6个月至2岁)的35.9%上升至青少年和成年人的近100%,各年龄组的抗体水平有所不同。与历史数据的比较表明儿童期早期EBV感染的趋势一致,但感染增长速度比过去略慢。与其他国家相比,泰国和其他发展中国家的EBV血清阳性率比发达国家出现得更早。线性回归分析显示,50%和75%EBV血清阳性时的年龄与一项国家经济指标(人均国内生产总值)之间存在显著相关性。这些发现表明EBV流行病学随时间变化不大,并提供了最新信息和分析以支持公共卫生策略。
J Virol Methods. 2024-9
Cochrane Database Syst Rev. 2022-11-17
Am J Trop Med Hyg. 2025-3-18
Mult Scler Relat Disord. 2024-4
Asian Pac J Cancer Prev. 2015
J Immunoassay Immunochem. 2022-1-2
BMC Public Health. 2020-6-12
New Microbes New Infect. 2020-1-7
BMC Infect Dis. 2019-11-28
Adv Exp Med Biol. 2018
Isr Med Assoc J. 2018-2